Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Challenges assessing clinical endpoints in early Huntington disease
The PREDICT-HD Investigators of the Huntington Study Group
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Section of Movement Disorders
Neuroimaging Labs Research Center
DBBS - Neurosciences
Hope Center for Neurological Disorders
Research output
:
Contribution to journal
›
Article
›
peer-review
73
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Challenges assessing clinical endpoints in early Huntington disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Trials
100%
Loss Function
100%
Huntington's Disease
100%
Clinical Endpoints
100%
Prodrome
66%
Disease Diagnosis
33%
Survival Analysis
33%
Disease-modifying Therapy
33%
Genetic Testing
33%
Early Disease
33%
Clinical Symptoms
33%
Clinical Signs
33%
Brain Diseases
33%
Prospective Evaluation
33%
Life Functioning
33%
Functional Scale
33%
Job Change
33%
Psychiatric Measures
33%
Gene Carrier
33%
Cognitive-motor Training
33%
Cognitive Measures
33%
Clinically Diagnosed
33%
Longitudinal Observational Study
33%
Nursing and Health Professions
Huntington Chorea
100%
Diseases
100%
Clinical Trial
100%
Survival Analysis
33%
Functional Status
33%
Physical Disease by Body Function
33%
Genetic Screening
33%
Brain Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Huntington Chorea
100%
Diseases
100%
Prospective Study
33%
Functional Status
33%
Observational Study
33%
Physical Disease by Body Function
33%
Brain Disease
33%
Neuroscience
Huntington's Disease
100%
Survival Analysis
100%
Brain Disease
100%
Genetics
100%